Predictive toxicology & liver cell based screening" title="" class="btn" data-container="body" data-html="true" data-id="158469" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Cytochroma"> 257 5 1,051
Activities
Technologies
Entity types
Location
Easter Bush Campus, Roslin EH25 9RG, UK
Edinburgh
United Kingdom
Employees
Scale: 1-10, 2-10
Estimated: 4
Engaged corporates
2Added in Motherbase
3 years agoAccelerating global drug development
Cytochroma predict how drugs will react in a global population in health or disease.
Our unique, ethnically diverse library of iPSC and automated cell culture generates robust, reliable, mature hepatocytes for toxicity testing.
We are supporting life science companies, de-risking safe compounds prior to clinical testing, making new drug development faster, safer and more efficient.
toxicity testing, liver specialists, hepatocyte testing, disease models, high throughput, high content screening, iPSC, automated manufacture, machine learning, artificial intelligence, predictive testing, and pre clinical testing
Cytochroma manufacture iPSC derived hepatocytes, cardiomyocytes, endothelial cells and fibroblasts for preclinical testing. Polarised, metabolic and highly functional Cytochrome P450 expressing hepatocytes. Complex, self organising cardiomyocyte models from isogenic fibroblasts and endothelial cells. Genetically diverse models, DILI testing and phenotypic screening. Tiny organs big impact
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Jun 2022 | | |
![]() UK Atomic Energy Authority Research, National and local authorities | UK Atomic Energy Authority Research, National and local authorities | Other 31 Dec 2021 | |